周開平（Kai-Ping Chow）

Appointment : Associate Professor

Lab：Tumor Immunology Research Laboratory

Education : Ph.D.

University/Nation：Case Western Reserve University, USA

Tel: (03)2118800 ext. 5138

E-mail : kpc@mail.cgu.edu.tw

Research website : 

Research interests:

 Immune regulation targeting tumor angiogenesis

Publications:

1. Kai-Ping N Chow, C C Wu, H Y Chang, C Chang and Y S Chang. 2008. Mar. A simplified tumor model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived ontogeny latent membrane protein 1 inimmunocompetent mice. Lab Animal. 42(2):192-208

1. B N Sathy, Y H Chou, H J Li, C Chang and K P N Chow. 2009. Jan. Dynamic contrast-enhanced and T2-weighted MRI study of the correlation between tumor angiogenesis and growth kinetics. Lab Animal. 43(1): 53-59
2. Yen-Yu I. Shih, Yi-Hue Hsu, Timothy Q. Duong, Sui-Shan Lin, Kai-Ping N. Chow and Chen Chang. 2011. Dec. Longitudinal study of tumor-associated macrophages during tumor expansion using MRI. NMR in Biomedicine. 4(24):1353-1360
3. Kai-Ping N. Chow, Jan-Mou Lee, Jian-Tai Qiu, Shuen-Kuei Liao, Shih-ChiehLin, Shuo-Lun Hsu, Ning-Ning Wu, Yen-Fu Lin, Tzong-Shoon Wu. 2011. Nov. Enhanced IL-10 production by CD4+ T cells primed in IL-15Rα-deficient mice. European Journal of Immunology. 41(11):3146-3156
4. Zchong-Zcho Wu, Kai-Ping N. Chow, Tzu-Ching Kuo, Yu-Sun Chang, Chuck C.-K. Chao. 2011. Dec. Latent membrane protein 1 of Epstein–Barr virus sensitizes cancer cells to cisplatin by enhancing NF-kB p50 homodimerformation and downregulating NAPA expression. Biochemical Pharmacology. 82(12):1860-1872
5. Chow, K.-P.N, J.-T.,Lee, J.-M.,Hsu, S.-L.,Yang, S.-C.,Wu, N.-N.,Huang,W.,Wu, T.-S. 2012. Mar. Selective reduction of post-selection CD8 thymocyteproliferation in IL-15Rα deficient mice. PLoS ONE. 7(3):e33152